Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937308 · ClinicalTrials.gov registry record · NA
NEUROMARK Registry Study
A NA study of Chronic Rhinitis, sponsored by Neurent Medical.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 7
- Study locations
NCT05937308: Active NA study of Chronic Rhinitis, sponsored by Neurent Medical.
NCT05937308 is a NA study of Chronic Rhinitis that is active but no longer recruiting, run by Neurent Medical. The registered enrollment target is 150 participants, above the 72-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (108% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05937308, a NA study of Chronic Rhinitis, is active but no longer recruiting, sponsored by Neurent Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 7
- Study locations
Study Summary
The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.
Primary Outcome
Safety, as assessed by the incidence of device- and/or procedure-related serious adverse events (SAEs).
Conditions Studied
Interventions
- DEVICE NEUROMARK System
Study Locations (7)
California
- Sensa Health - Los Angeles
- Sacramento ENT - Roseville
Alabama
- Alabama Nasal & Sinus Center - Birmingham
Florida
- Florida ENT & Allergy - Brandon
Texas
- ENT & Allergy Texas - McKinney
Utah
- Ogden Clinic - Ogden
Virginia
- Metropolitan ENT - Alexandria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2027-09 |
| Phase | NA |
What the registry record for NCT05937308 still lists
NCT05937308 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, above the 72-participant average among 6 other Chronic Rhinitis trials with a reported enrollment target (108% higher).
The record links to 1 condition, with Chronic Rhinitis appearing as the primary indexed condition, and to 1 intervention - of which NEUROMARK System is the first listed.
NCT05937308 lists 7 locations in 6 states (California, Alabama, Florida).
Frequently Asked Questions
What is clinical trial NCT05937308 about?
NCT05937308 is a clinical study titled "NEUROMARK Registry Study". The NEUROMARK Registry Study is a prospective, multicenter, single-arm, post-market, interventional registry study to collect real-world evidence of the NEUROMARK System in subjects with chronic rhinitis.
What is the current status of trial NCT05937308?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2023-06-12. Estimated completion is 2027-09.
What conditions does trial NCT05937308 study?
This clinical trial studies the following conditions: Chronic Rhinitis.
What interventions are being tested in trial NCT05937308?
The interventions under investigation include: NEUROMARK System (DEVICE).
Who is sponsoring clinical trial NCT05937308?
This trial is sponsored by Neurent Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05937308 being conducted?
This trial has 7 study locations across Alabama, California, Florida, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Rhinitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of RhinAer Stylus for Treating Chronic Rhinitis
ACTIVE NOT RECRUITING · NA
-
Multi-Treatment PNN Modulation for Chronic Rhinitis
COMPLETED · NA
-
ClariFix Rhinitis RCT
COMPLETED · NA
-
Safety and Efficacy Study of the Neurent Medical NEUROMARK™ System in Subjects With Chronic Rhinitis (CLARITY)
COMPLETED · NA
-
A Study of RhinAer ARC Stylus for Treating Chronic Rhinitis (RELIEF)
COMPLETED · NA
-
Efficacy of Azelastine and Mometasone Irrigation in Comparison to Nasal Sprays in Patients With Chronic Rhinitis
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI